Blau Farmacêutica S.A. (BVMF:BLAU3)

Market Cap	2.13B
Revenue (ttm)	1.69B
Net Income (ttm)	187.05M
Shares Out	177.68M
EPS (ttm)	1.05
PE Ratio	11.36
Forward PE	7.48
Dividend	n/a
Ex-Dividend Date	Sep 27, 2024

Volume	230,100
Average Volume	163,615
Open	12.49
Previous Close	12.75
Day's Range	12.49 - 13.34
52-Week Range	9.20 - 17.61
Beta	0.36
RSI	44.07
Earnings Date	Mar 19, 2025

About Blau Farmacêutica

Blau Farmacêutica S.A., a pharmaceutical company provides high-complpexity drugs in Brazil, Argentina, Chile, Colombia, Uruguay, Ecuador, Peru, and the United States. Its medications cover various segments, such as immunology, hematology, oncology, nephrology, infectious diseases, anesthesiology, and others. The company provides uterine stimulator; anesthetics; feminine health care; oncological products; antivirals and antiretrovirals; acid pump inhibitor; antithrombotic; antirheumatic; antibiotics; biopharmaceuticals; essential hospital produc...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1987
• Employees: 1,900
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: BLAU3

Financial Performance

In 2023, Blau Farmacêutica's revenue was 1.37 billion, a decrease of -2.44% compared to the previous year's 1.41 billion. Earnings were 249.81 million, a decrease of -31.25%.